SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
375Now if he could just show a little gratitude to the company that came up with itdalroi-6/9/2003
374Adjunctive Use of Antifibrotic Agents Geoffrey P. Schwartz, MD, and Steven J.keokalani'nui-6/5/2003
373Or DNA / CLL ?nigel bates-6/4/2003
372>>If Abbott's claims are upheld, then royalty payments could slip to akeokalani'nui-6/4/2003
371Not really, no, and no. (edit) Unless we're talking about royalty disputes.nigel bates-5/30/2003
370Nigel, I haven't been paying attention, so question: Does CATG react to thtuck-5/30/2003
369CAMBRIDGE, England, May 30 /PRNewswire-FirstCall/ -- Cambridge Antibody Technolonigel bates-5/30/2003
368<i>White said he expects Humira could be a "multibillion dollar"nigel bates-5/29/2003
367>>NEW YORK, May 29 (Reuters) - Abbott Laboratories Inc. (NYSE:ABT - News) tuck-5/29/2003
366LONDON (Dow Jones)--Cambridge Antibody Technology Friday acknowledges the announnigel bates-5/23/2003
365>>ABBOTT PARK, Ill., May 22 /PRNewswire-FirstCall/ -- Abbott Laboratories tuck-5/22/2003
364Cambridge Antibody Says Abbott Flap May End Up In Court Monday May 19, 6:50 am Enigel bates-5/19/2003
363<pre>CAMBRIDGE ANTIBODY TECHNOLOGY GROUP plc RESULTS FOR THE SIX MONTHnigel bates-5/19/2003
362Cambridge Antibody Technology Interim Results for the Six Months Ended 31 March nigel bates-5/19/2003
361ARDM takes on Weston assets - Message 18938841nigel bates-5/14/2003
360Never heard of them, but Lonza signed a 12 month technology evaluation deal withnigel bates-5/14/2003
359Chromos announces ACE System deal with Cambridge Antibody Technology for the comnigel bates-5/14/2003
358Alizyme mentioned in the FT as a another possible merger partner for CAT. Cannigel bates-4/29/2003
357Progress on LymphoStat-B: Message 18864358 <i>...HGSI announced today thatnigel bates-4/21/2003
356Wellington Management Reports 7% Cambridge Antibody Stake Thursday April 10, 12:nigel bates-4/10/2003
355From Abbott statement - <pre> Q2) What is the status of the HUMIRA nigel bates-4/9/2003
354>>CHICAGO (Dow Jones)--Abbott Laboratories makes lots of drugs. But when ituck-4/7/2003
353<pre>Cambridge Antibody Tech Group PLC 01 April 2003 nigel bates-4/3/2003
352Re DYAX, this from the 10K (which includes the XOMA license agreement, but apparnigel bates-3/28/2003
351Whether abt's other licensor was "needed" will provide for a nice keokalani'nui-3/26/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News